NCT01972464View on ClinicalTrials.gov

Progesterone for Smoking Relapse Prevention Following Delivery

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions
Tobacco Use Disorder
Interventions
DRUG

Progesterone

oral micronized progesterone

DRUG

Placebo

Trial Locations (1)

06510

Yale School of Medicine Dpt of Psychiatry, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT01972464 - Progesterone for Smoking Relapse Prevention Following Delivery | Biotech Hunter | Biotech Hunter